- OUTLOOK
The sickle-cell drug boon
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 596, S8-S9 (2021)
doi: https://doi.org/10.1038/d41586-021-02141-1
This article is part of Nature Outlook: Sickle-cell disease, an editorially independent supplement produced with the financial support of third parties. About this content.
References
Poillon, W. N., Kim, B. C. & Castro, O. Blood 91, 1777–1783 (1998).
Antwi-Boasiako, C. et al. Med. Sci. 7, 17 (2019).
Blair, H. A. Drugs 80, 209–215 (2020).
Vinchi, F. et al. Blood 127, 473–486 (2016).
Farooq, F., Mogayzel, P. J., Lanzkron, S., Haywood, C. & Strouse, J. J. JAMA Netw. Open 3, e201737 (2020).